CONTENTS
Autumn 2026
Features
8 SPOT LIGHT
Green electricity has an important role to play in making pharmaceutical manufacturing more sustainable. Translating environmental objectives into practical progress, however, requires renewable energy solutions tailored to each site’s infrastructure, electricity demands and operational requirements.
Manufacturing
Could digital integration and smarter workflows transform the NHS’s pre-analytical process and improve patient safety?
As bioprocessing becomes more connected and data-driven, can protein quantitation move beyond the lab to deliver more actionable insights where they matter most?
How can downstream processing keep pace with increasingly complex biologics? Greater selectivity and process intensification could help build more flexible and efficient purification strategies.
Digital
What if every experiment could inform the next? Lab-in-a-loop architectures are bringing scientific reasoning and automation together to accelerate biopharmaceutical R&D.
AI is accelerating antibody design. Can lab validation keep up?
Artificial intelligence can generate antibody sequences far faster than conventional expression workflows can test them. A fit-for-purpose cell-free triage layer can turn digital designs into early expression and binding evidence, while reserving mammalian systems for the questions only they can answer.
Lab Design
How do you design laboratories that can accommodate capabilities you don’t yet know you’ll need? As pharmaceutical pipelines diversify, that question is becoming central to lab planning.
Imaging and Sensing
Ensuring accurate vessel pressure control can be crucial for process quality. To achieve this, optimising valve response time is key, which means that integrated, sterilisation-in-place-capable systems can have an important advantage.
Discovery and Design
IPT speaks to Ali T at LotusDx about the challenges for accessible diagnostics, from developing accurate and user-friendly at-home tests to building trust and connecting testing with effective healthcare pathways.
The health and nutritional benefits of vitamins are well known, but they are becoming increasingly important to drug developers for their value as multifunctional excipients.
Regulars
IPT highlights some of the most recent exciting advancements in pharmaceutical manufacturing.
A collation of the top Pharma events for Autumn 2026!
EXECUTIVE DIRECTOR
PMGroup Worldwide Ltd
Karl Equi
GROUP MANAGING EDITOR
PMGroup Worldwide Ltd
Iona Everson
DEPUTY EDITORS
Amber O'Rourke
Yasmin Nolan
MEDIA MANAGER
Louise White
DESIGN
Peter May
FRONT COVER
New AfricaShutterstock
DIGITAL EDITION
IPT Online
www.iptonline.com
CONTACT US
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
PRINTING
Pureprint Group
www.pureprint.com
SUBSCRIPTIONS AND DATA
Curwood CMS Ltd
Unit 9 Barns & Stables,
Timworth Green,
IP31 1HS
c-cms.com
Tel: 01580 883841
Email: enquiries@c-cms.com
www.iptonline.com
Innovations in Pharmaceutical Technology (ISSN: 1471-7204, USPS No: 025082) is published four times a year – March, June, September, and December – by Samedan Ltd.
The opinions and views expressed by the authors in this book are not necessarily those of the Editor the Publisher and, while every care has been taken in the preparation of the book, the Editor and the Publisher are not responsible for such opinions and views or for
any inaccuracies in the articles.
The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred.
The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form, by any means – electronic,
mechanical, photocopying, or otherwise – without the prior permission of the Publisher.
© 2026 Samedan Ltd
Pharmaceutical Publishers
Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.